BruceDavidChesonMD
Oncology • Washington, DCHematologic Oncology
Professor, Medicine, Georgetown University School of Medicine
Dr. Cheson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-2198- Is this information wrong?
Education & Training
Tufts University School of MedicineClass of 1971
University of Virginia Medical CenterResidency, Internal Medicine
Certifications & Licensure
MD State Medical License 1987 - 2024
DC State Medical License 1994 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2008 Feb 01
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) Start of enrollment: 2009 Feb 01
- Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D Cheson, Nancy L Bartlett, Sumithra J Ma...> ;Blood Advances. 2024 Mar 26
- A man's best friend is his PET.Bruce D Cheson> ;Blood. 2023 Jun 22
- 2 citationsEuropean Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours.Cristina Nanni, Carsten Kobe, Bettina Baeßler, Christian Baues, Ronald Boellaard, Peter Borchmann, Andreas Buck, Irène Buvat, Björn Chapuy, Bruce D Cheson, Robert Chrz...> ;The Lancet. Haematology. 2023 May 1
- Join now to see all
Journal Articles
- Combinations or Sequences of Targeted Agents in CLL: Is the Whole Greater Than the Sum of Its Parts (Aristotle, 360 BC)?Bruce Cheson, MD, Blood
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
- Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United StatesArun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica
Abstracts/Posters
- Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analys...Bruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- North American Practice Patterns for PET-2 Positive Hodgkin LymphomaBruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel TherapiesBruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia (Part 1 of a 2-Part Series)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Bortezomib Maintenance (BM) or Consolidation (BC) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (ASCT) for Untreated Mantle Cell Lymphoma...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
4 Oncologists on the MoveJune 8th, 2021- Brentuximab Vedotin plus Nivolumab as Chemotherapy-Free Strategy for Hodgkin Lymphoma in Older PatientsOctober 19th, 2020
Thanks. Feedback Improves Google AdsSeptember 17th, 2019- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
MedStar Georgetown University HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
